Prasugrel or Ticagrelor for atrial fibrillation

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Jul 2021: Trial registered, NCT04981041
  2. 16 Dec 2021: Trial started, NCT04981041

The trials

NCT04981041: Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI

State
Completed
Phase
Phase 4
People
602 taking part
Started
16 Dec 2021
Primary completion
22 May 2026
Arms
Potent P2Y12-Inhibition
Results
None posted
  1. 28 Jul 2021: Trial registered
  2. 16 Dec 2021: Trial started
  3. 30 May 2026: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.